What's breaking now, across thousands of outlets.
Massachusetts biotech Scholar Rock said it's pulling an embattled Indiana-based manufacturing site from its application for a potential new spinal muscular atrophy drug, after the site was again cited for deficiencies by the FDA following ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study.
Type 2 diabetes usually develops over many years, yet preventive measures often begin only once blood glucose levels are already elevated.
Health: Latin America Key Facts —Dengue surge. In epidemiological week 12 of 2026, the Americas reported 624,085 suspected dengue cases, a cumulative incidence of 62 per 100,000 population — a 64%…
Health data is classified as sensitive and personal and may only be processed by a healthcare...
Access to accurate information about reproductive and maternal health can be critical. But on Meta's platforms, simply talking about prescription medication, abortion care, or one's own medical…
[Leadership] A new US-Nigeria healthcare partnership, Atunse Healthcare Limited, has launched operations with a focus on regenerative medicine and advanced treatment, as part of efforts to reduce…
